NRXP (NRX Pharmaceuticals) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NRXP NRX Pharmaceuticals Inc NRXP
29 GF Score
Price $4.10
! 4 Warning Signs
View Full Analysis

What is NRX Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

NRXP
29GF Score
NRX Pharmaceuticals Inc NRXP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NRX Pharmaceuticals Business Description

Other Exchanges B1Q:Germany
Address 1201 Orange Street, Suite 600, Wilmington, DE, USA, 19801
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
29GF Score

Get the complete analysis for NRXP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.10
Price